Law360 (January 14, 2020, 3:39 PM EST) -- Goodwin Procter LLP landed a major win for Teva Pharmaceuticals in a U.S. Supreme Court decision that clarified the scope of the so-called on-sale bar under the America Invents Act, as well as helped Dr. Reddy's Laboratories defend its generic version of an opioid treatment, earning the firm a spot among Law360's 2019 Intellectual Property Groups of the Year.
Daryl Wiesen, the firm's intellectual property litigation group chairman, told Law360 that the firm's IP practice is "comprehensive" in its coverage, including in subject matter and courts — something the team has worked hard to accomplish.
Wiesen said that the group, which includes...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!